Scarica l'app Stockscreener
92.92
0.01%
-0.01
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$92.93
Aprire:
$92.2
Volume 24 ore:
19.44M
Relative Volume:
1.62
Capitalizzazione di mercato:
$232.09B
Reddito:
$63.90B
Utile/perdita netta:
$19.05B
Rapporto P/E:
12.29
EPS:
7.5596
Flusso di cassa netto:
$13.05B
1 W Prestazione:
+7.70%
1M Prestazione:
+9.70%
6M Prestazione:
+26.47%
1 anno Prestazione:
-5.53%
Intervallo 1D:
$91.49
$95.08
Intervallo di 1 settimana:
$85.80
$95.08
Portata 52W:
$73.31
$105.07
Merck Co Inc Stock (MRK) Company Profile
Nome
Merck Co Inc
Settore
Industria
Telefono
908-740-4000
Indirizzo
126 EAST LINCOLN AVENUE, RAHWAY, NJ
Confronta MRK con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
MRK
Merck Co Inc
|
92.92 | 230.65B | 63.90B | 19.05B | 13.05B | 7.5596 |
|
LLY
Lilly Eli Co
|
1,025.28 | 915.49B | 59.42B | 18.41B | 6.44B | 20.22 |
|
JNJ
Johnson Johnson
|
195.93 | 470.41B | 92.15B | 25.12B | 20.46B | 10.36 |
|
ABBV
Abbvie Inc
|
232.36 | 410.55B | 59.64B | 2.36B | 19.68B | 1.3253 |
|
NVS
Novartis Ag Adr
|
131.26 | 253.11B | 54.45B | 14.42B | 17.15B | 7.333 |
Merck Co Inc Stock (MRK) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-10-13 | Ripresa | Citigroup | Neutral |
| 2025-09-17 | Downgrade | Berenberg | Buy → Hold |
| 2025-05-14 | Downgrade | Citigroup | Buy → Neutral |
| 2025-04-22 | Iniziato | Cantor Fitzgerald | Neutral |
| 2025-02-18 | Downgrade | Deutsche Bank | Buy → Hold |
| 2025-02-10 | Downgrade | TD Cowen | Buy → Hold |
| 2025-01-08 | Downgrade | Truist | Buy → Hold |
| 2024-12-20 | Downgrade | BMO Capital Markets | Outperform → Market Perform |
| 2024-12-10 | Ripresa | BofA Securities | Buy |
| 2024-12-04 | Aggiornamento | HSBC Securities | Hold → Buy |
| 2024-11-15 | Iniziato | Wolfe Research | Peer Perform |
| 2024-11-11 | Downgrade | Daiwa Securities | Buy → Neutral |
| 2024-10-17 | Iniziato | Bernstein | Mkt Perform |
| 2024-03-11 | Downgrade | Societe Generale | Hold → Sell |
| 2024-01-04 | Aggiornamento | TD Cowen | Market Perform → Outperform |
| 2023-11-09 | Iniziato | Deutsche Bank | Buy |
| 2023-10-27 | Aggiornamento | BMO Capital Markets | Market Perform → Outperform |
| 2023-10-20 | Aggiornamento | UBS | Neutral → Buy |
| 2023-07-14 | Iniziato | HSBC Securities | Hold |
| 2023-04-13 | Aggiornamento | Citigroup | Neutral → Buy |
| 2023-03-28 | Downgrade | Societe Generale | Buy → Hold |
| 2023-03-13 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2023-03-06 | Iniziato | Jefferies | Buy |
| 2023-02-22 | Aggiornamento | Wolfe Research | Peer Perform → Outperform |
| 2023-01-04 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2022-11-18 | Iniziato | Credit Suisse | Outperform |
| 2022-10-10 | Aggiornamento | Guggenheim | Neutral → Buy |
| 2022-09-14 | Aggiornamento | Berenberg | Hold → Buy |
| 2022-07-06 | Aggiornamento | Daiwa Securities | Neutral → Buy |
| 2022-06-06 | Ripresa | SVB Leerink | Outperform |
| 2022-04-06 | Ripresa | Morgan Stanley | Equal-Weight |
| 2021-12-17 | Iniziato | Goldman | Buy |
| 2021-12-16 | Iniziato | Daiwa Securities | Neutral |
| 2021-12-13 | Downgrade | UBS | Buy → Neutral |
| 2021-12-09 | Iniziato | Wells Fargo | Overweight |
| 2021-12-07 | Downgrade | Guggenheim | Buy → Neutral |
| 2021-11-29 | Downgrade | Citigroup | Buy → Neutral |
| 2021-11-19 | Iniziato | BMO Capital Markets | Market Perform |
| 2021-11-01 | Aggiornamento | Argus | Hold → Buy |
| 2021-09-07 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2021-07-27 | Ripresa | Truist | Buy |
| 2021-05-20 | Downgrade | Argus | Buy → Hold |
| 2021-04-07 | Ripresa | RBC Capital Mkts | Sector Perform |
| 2020-11-10 | Ripresa | Bernstein | Outperform |
| 2020-09-29 | Iniziato | Berenberg | Hold |
| 2020-08-03 | Aggiornamento | Goldman | Neutral → Buy |
| 2020-06-12 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| 2020-02-27 | Iniziato | Barclays | Overweight |
| 2020-01-07 | Iniziato | RBC Capital Mkts | Sector Perform |
| 2019-10-17 | Ripresa | BofA/Merrill | Neutral |
| 2019-08-16 | Iniziato | SVB Leerink | Outperform |
| 2019-07-03 | Iniziato | Mizuho | Buy |
| 2019-05-28 | Iniziato | Goldman | Neutral |
| 2019-05-13 | Aggiornamento | Atlantic Equities | Neutral → Overweight |
| 2018-10-16 | Reiterato | Citigroup | Buy |
| 2018-10-09 | Ripresa | Guggenheim | Buy |
| 2018-04-23 | Aggiornamento | Goldman | Neutral → Buy |
| 2018-04-17 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2018-04-05 | Aggiornamento | Barclays | Equal Weight → Overweight |
| 2018-03-12 | Aggiornamento | Leerink Partners | Mkt Perform → Outperform |
| 2018-02-14 | Reiterato | Leerink Partners | Mkt Perform |
| 2018-02-07 | Reiterato | Morgan Stanley | Equal-Weight |
| 2018-01-16 | Aggiornamento | SunTrust | Hold → Buy |
Mostra tutto
Merck Co Inc Borsa (MRK) Ultime notizie
Intech Investment Management LLC Trims Stock Holdings in Merck & Co., Inc. $MRK - MarketBeat
Sculati Wealth Management LLC Reduces Holdings in Merck & Co., Inc. $MRK - MarketBeat
OmniStar Financial Group Inc. Has $1.10 Million Stock Position in Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. (NYSE:MRK) Receives Consensus Rating of "Hold" from Analysts - MarketBeat
Merck & Co., Inc. $MRK Stock Position Raised by Advisors Capital Management LLC - MarketBeat
Merck Offers $9.2bn To Buy Cidara And Phase III Antiviral Flu Preventative - Citeline News & Insights
Merck buys Cidara for $9.2B as Keytruda patent loss looms - BioWorld MedTech
Merck Buys Cidara For $9.2 Billion To Add Flu Drug - Finimize
Merck agrees $9.2bn deal for flu-prevention biotech Cidara - Financial Times
Merck to Acquire Cidara Therapeutics in $9.2 Billion Deal - Bloomberg.com
What's Going On With Merck Stock Friday?Merck & Co (NYSE:MRK), Cidara Therapeutics (NASDAQ:CDTX) - Benzinga
Merck to acquire Cidara Therapeutics for $9.2B - Proactive financial news
Do You Believe in Merck & Co.’s (MRK) Upside Potential? - Insider Monkey
Olympiad Research LP Makes New Investment in Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. agreed to acquire Cidara Therapeutics, Inc.. - MarketScreener
Grandfield & Dodd LLC Has $15.28 Million Stake in Merck & Co., Inc. $MRK - MarketBeat
Oak Harvest Investment Services Purchases 4,194 Shares of Merck & Co., Inc. $MRK - MarketBeat
Phoenix Wealth Advisors Cuts Position in Merck & Co., Inc. $MRK - MarketBeat
Good Life Advisors LLC Grows Position in Merck & Co., Inc. $MRK - MarketBeat
Impax Asset Management Group plc Sells 252,213 Shares of Merck & Co., Inc. $MRK - MarketBeat
Merck to acquire Cidara for $221.50/share in $9.2 billion deal; CDTX soars (MRK:NYSE) - Seeking Alpha
Merck to Acquire Cidara Therapeutics, Inc., Diversifying Its Portfolio to Include Late-Phase Antiviral Agent - Business Wire
MerckBacillus of Calmette and Guerin (BCG) Vaccine for Percutaneous UseBrochure - Environmental XPRT
Donoghue Forlines LLC Acquires 2,755 Shares of Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. $MRK Shares Sold by Burling Wealth Partners LLC - MarketBeat
Banco Bilbao Vizcaya Argentaria S.A. Has $37.66 Million Holdings in Merck & Co., Inc. $MRK - MarketBeat
Belén Garijo’s prescription for Germany’s Merck - https-//www.semafor.com
Merck (MRK) Delivers Strong Q3 2025 Earnings as Oncology Sales Drive Revenue Growth - MSN
Scotiabank Begins Coverage on Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Thompson Davis & CO. Inc. Makes New $1.17 Million Investment in Merck & Co., Inc. $MRK - MarketBeat
Police & Firemen s Retirement System of New Jersey Raises Stock Holdings in Merck & Co., Inc. $MRK - MarketBeat
Merck to Participate in the Jefferies Global Healthcare Conference in London - Business Wire
Scotiabank Initiates Merck & Co. at Sector Outperform With $105 Price Target - MarketScreener
Cherokee Insurance Co Buys New Position in Merck & Co., Inc. $MRK - MarketBeat
Candriam S.C.A. Sells 494,389 Shares of Merck & Co., Inc. $MRK - MarketBeat
Bailard Inc. Buys 9,336 Shares of Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. $MRK Shares Sold by Boston Partners - MarketBeat
1 Incredible Reason to Buy LLY's Stock in November - The Motley Fool
Avalon Trust Co Has $1.49 Million Position in Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. $MRK Stake Lessened by Atlanta Consulting Group Advisors LLC - MarketBeat
Insider Sell: Cristal Downing Sells 7,085 Shares of Merck & Co I - GuruFocus
Merck & Co. Insider Sold Shares Worth $616,395, According to a Recent SEC Filing - MarketScreener
Geode Capital Management LLC Cuts Position in Merck & Co., Inc. $MRK - MarketBeat
Renasant Bank Purchases 7,966 Shares of Merck & Co., Inc. $MRK - MarketBeat
PNC Financial Services Group Inc. Reduces Holdings in Merck & Co., Inc. $MRK - MarketBeat
Kelleher Financial Advisors Has $816,000 Holdings in Merck & Co., Inc. $MRK - MarketBeat
United Asset Strategies Inc. Increases Position in Merck & Co., Inc. $MRK - MarketBeat
Tobam Sells 8,861 Shares of Merck & Co., Inc. $MRK - MarketBeat
Mitsubishi UFJ Trust & Banking Corp Acquires 74,494 Shares of Merck & Co., Inc. $MRK - MarketBeat
M&G PLC Sells 85,084 Shares of Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. $MRK Shares Purchased by KBC Group NV - MarketBeat
Merck Co Inc Azioni (MRK) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.49%
0.22%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):